IN01

N/A

Report date: 2024/11/23 20:00:08

Base Information

Drug NameIN01
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInstituto Oncológico Dr. RosellIn3Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstituto Oncológico Dr. RosellIn3Bio Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A